ScandiDos AB (publ)

OM:SDOS Stock Report

Market Cap: SEK 93.5m

ScandiDos Valuation

Is SDOS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SDOS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SDOS (SEK1.64) is trading below our estimate of fair value (SEK4.43)

Significantly Below Fair Value: SDOS is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SDOS?

Key metric: As SDOS is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SDOS. This is calculated by dividing SDOS's market cap by their current revenue.
What is SDOS's PS Ratio?
PS Ratio1.5x
SalesSEK 63.19m
Market CapSEK 93.50m

Price to Sales Ratio vs Peers

How does SDOS's PS Ratio compare to its peers?

The above table shows the PS ratio for SDOS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average5.4x
GTAB B Glycorex Transplantation
4.3xn/aSEK 144.0m
EPIS B Episurf Medical
7.9x93.5%SEK 98.2m
NOSA Nosa Plugs
8.4x38.5%SEK 125.1m
DIGN Dignitana
1.1x19.3%SEK 96.7m
SDOS ScandiDos
1.5xn/aSEK 93.5m

Price-To-Sales vs Peers: SDOS is good value based on its Price-To-Sales Ratio (1.5x) compared to the peer average (5.4x).

Price to Sales Ratio vs Industry

How does SDOS's PS Ratio compare vs other companies in the SE Medical Equipment Industry?

12 CompaniesPrice / SalesEstimated GrowthMarket Cap
ARJO B Arjo
0.8x3.6%US$808.67m
CARE Careium
0.8x10.2%US$62.46m
BOUL Boule Diagnostics
0.5x5.6%US$23.73m
ARCOMA Arcoma
0.8x8.3%US$13.05m
SDOS 1.5xIndustry Avg. 4.7xNo. of Companies12PS048121620+
12 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: SDOS is good value based on its Price-To-Sales Ratio (1.5x) compared to the Swedish Medical Equipment industry average (4.7x).

Price to Sales Ratio vs Fair Ratio

What is SDOS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SDOS PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.5x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate SDOS's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Arcoma

SEK 144.4m

Develops, produces, and provides radiology solutions worldwide.

ARCOMA

SEK 10.95

7D

1.4%

1Y

47.0%

Dignitana

SEK 96.7m

A medical technology company, engages in the development, production, and marketing of medical cooling devices in the United States and internationally.

DIGN

SEK 1.20

7D

4.3%

1Y

-45.5%

Iconovo

SEK 79.9m

Develops and licenses inhalation medications in Sweden.

ICO

SEK 5.02

7D

-1.6%

1Y

-46.3%